000 | 01647 a2200457 4500 | ||
---|---|---|---|
005 | 20250513092732.0 | ||
264 | 0 | _c19960823 | |
008 | 199608s 0 0 eng d | ||
022 | _a0028-1298 | ||
024 | 7 |
_a10.1007/BF00168639 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLeza, J C | |
245 | 0 | 0 |
_aCorrelation between brain nitric oxide synthase activity and opiate withdrawal. _h[electronic resource] |
260 |
_bNaunyn-Schmiedeberg's archives of pharmacology _cFeb 1996 |
||
300 |
_a349-54 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aArginine _xadministration & dosage |
650 | 0 | 4 |
_aCerebellum _xdrug effects |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 | _aInjections, Subcutaneous |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aMorphine Dependence _xenzymology |
650 | 0 | 4 | _aNG-Nitroarginine Methyl Ester |
650 | 0 | 4 |
_aNaloxone _xadministration & dosage |
650 | 0 | 4 |
_aNarcotic Antagonists _xadministration & dosage |
650 | 0 | 4 |
_aNarcotics _xmetabolism |
650 | 0 | 4 |
_aNitric Oxide _xbiosynthesis |
650 | 0 | 4 |
_aNitric Oxide Synthase _xantagonists & inhibitors |
650 | 0 | 4 | _aStereoisomerism |
650 | 0 | 4 |
_aSubstance Withdrawal Syndrome _xdrug therapy |
700 | 1 | _aLizasoain, I | |
700 | 1 | _aCuéllar, B | |
700 | 1 | _aMoro, M A | |
700 | 1 | _aLorenzo, P | |
773 | 0 |
_tNaunyn-Schmiedeberg's archives of pharmacology _gvol. 353 _gno. 3 _gp. 349-54 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00168639 _zAvailable from publisher's website |
999 |
_c8689621 _d8689621 |